105 related articles for article (PubMed ID: 17923818)
1. Survival among children with medulloblastoma in Greece: gains from transition to chemotherapy and socio-economic differentials.
Moschovi M; Stavrou T; Dessypris N; Skalkidis I; Karalis D; Reaman GH; Goldstein AM; Prodromou N; Tzortzatou-Stathopoulou F; Petridou ET
Eur J Cancer Prev; 2007 Oct; 16(5):460-5. PubMed ID: 17923818
[TBL] [Abstract][Full Text] [Related]
2. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome and prognostic factors of medulloblastoma.
Wang KC; Lee JI; Cho BK; Kim IH; Kim JY; Shin HY; Ahn HS; Han DH
J Korean Med Sci; 1994 Feb; 9(1):64-73. PubMed ID: 8068221
[TBL] [Abstract][Full Text] [Related]
4. Multivariate survival analysis of children with medulloblastoma--a single-center experience.
Chen SH; Liu LY; Jaing TH; Tseng CK; Lin KL; Lui TN
Pediatr Hematol Oncol; 2008 Sep; 25(7):647-54. PubMed ID: 18850477
[TBL] [Abstract][Full Text] [Related]
5. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
Wang C; Yuan XJ; Jiang MW; Wang LF
J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
[TBL] [Abstract][Full Text] [Related]
7. Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocols.
Dhall G; Grodman H; Ji L; Sands S; Gardner S; Dunkel IJ; McCowage GB; Diez B; Allen JC; Gopalan A; Cornelius AS; Termuhlen A; Abromowitch M; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Jun; 50(6):1169-75. PubMed ID: 18293379
[TBL] [Abstract][Full Text] [Related]
8. [Role of adjuvant chemotherapy in the treatment of medulloblastoma in children].
Sachivko NV; Konoplia NE; Petrovich SV; Sharak EV
Vopr Onkol; 2002; 48(3):318-21. PubMed ID: 12455354
[TBL] [Abstract][Full Text] [Related]
9. Infants with medulloblastoma: a single institution review of survival.
Geyer R; Levy M; Berger MS; Milstein J; Griffin B; Bleyer WA
Neurosurgery; 1991 Nov; 29(5):707-10; discussion 710-1. PubMed ID: 1961400
[TBL] [Abstract][Full Text] [Related]
10. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.
Whitton AC; Syndikus I; Tait DM; Bloom HJ
Strahlenther Onkol; 1995 Nov; 171(11):615-21. PubMed ID: 7502224
[TBL] [Abstract][Full Text] [Related]
12. Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group.
Nageswara Rao AA; Wallace DJ; Billups C; Boyett JM; Gajjar A; Packer RJ
Pediatr Blood Cancer; 2014 Jan; 61(1):102-6. PubMed ID: 23956184
[TBL] [Abstract][Full Text] [Related]
13. [High-dose chemotherapy in relapse of medulloblastoma in young children].
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872
[TBL] [Abstract][Full Text] [Related]
14. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
Grill J; Sainte-Rose C; Jouvet A; Gentet JC; Lejars O; Frappaz D; Doz F; Rialland X; Pichon F; Bertozzi AI; Chastagner P; Couanet D; Habrand JL; Raquin MA; Le Deley MC; Kalifa C;
Lancet Oncol; 2005 Aug; 6(8):573-80. PubMed ID: 16054568
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy dose-intensity and survival for childhood medulloblastoma.
Smith RL; Shi X; Estlin EJ
Anticancer Res; 2012 Sep; 32(9):3885-92. PubMed ID: 22993333
[TBL] [Abstract][Full Text] [Related]
16. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
17. [Medulloblastoma: improved survival in recent decades. Unicentric experience].
Igual Estellés L; Berlanga Charriel P; Cañete Nieto A
An Pediatr (Barc); 2017 Jan; 86(1):4-10. PubMed ID: 27068068
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma: experience of a single institution.
Wolff JE; Huettermann U; Ritter J; Straeter R; Palm D; Ruebe C; Kraehling KH; Jürgens H
Klin Padiatr; 1998; 210(4):234-8. PubMed ID: 9743958
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastomas.
Gökalp HZ; Arasil E; Kanpolat Y; Erdogan A; Deda H; Unlü A
Neurochirurgia (Stuttg); 1993 May; 36(3):87-9. PubMed ID: 8321384
[TBL] [Abstract][Full Text] [Related]
20. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
